The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A novel small molecule inhibitor of p300/CBP for the treatment of castration-resistant prostate cancer: Preclinical evaluation.
 
Nigel Brooks
Employment - AstraZeneca (I); CellCentric
Stock and Other Ownership Interests - AstraZeneca; AstraZeneca (I)
 
Neil Pegg
Employment - CellCentric
Leadership - CellCentric
Stock and Other Ownership Interests - CellCentric
Consulting or Advisory Role - Pangaea Biotech
 
Jenny Worthington
Employment - Axis Bioservices
 
Barbara Young
Employment - Sygnature Discovery (I)
 
Amy Prosser
Employment - Sygnature Discovery
 
Jordan Lane
Employment - Sygnature Discovery
 
David Taddei
Employment - Sygnature Discovery
 
Matthew Joseph Schiewer
No Relationships to Disclose
 
Nicolas Gordon
No Relationships to Disclose
 
Karen E. Knudsen
Stock and Other Ownership Interests - Pfizer
Honoraria - Celgene; CellCentric
Consulting or Advisory Role - CellCentric
Research Funding - Celgene; Novartis; Sanofi